Consequences and management of COVID-19 on the care activity of an Inflammatory Bowel Disease Unit
- PMID: 33342217
- DOI: 10.17235/reed.2020.7543/2020
Consequences and management of COVID-19 on the care activity of an Inflammatory Bowel Disease Unit
Abstract
Introduction: COVID-19 has altered the usual practice of medicine and the state of emergency declared in Spain on March 14th has considerably changed the activity of inflammatory bowel disease (IBD) units. The aim of this study was to evaluate the consequences of COVID-19 on the IBD Unit's activity and provide information on restructuring with available resources.
Methods: an observational study was performed in a referral hospital in Madrid (Spain). Type of appointment, loss of follow-up, hospital admission, treatment changes, endoscopic activity, surgeries and blood tests were evaluated between March 15th and May 15th, 2020. This data was compared with the usual activity a year before.
Results: among the 510 patients included, 476 (93.33 %) received had a remote consultation, representing an increase of 92.38 % compared with the previous year (0.95 %). There was a loss of follow-up in 26 patients (5.1 %) vs 15 (3.58 %) the previous year. A total of 60 (35.09 %) blood tests, 64 (76.19 %) endoscopies and all scheduled surgeries were suspended. Besides, 484 (94.9 %) patients remained adherent vs 417/419 (99.5 %) in the pre-pandemic period and 48 (9.41 %) reported symptoms of an IBD flare. Thirty-nine (7.6 %) patients developed symptoms suggestive of COVID-19.
Conclusion: a large number of tests and on-site outpatient visit consultations were suspended. However, a rapid adaptation to telemedicine allowed these patients to be closely followed up. Although it was possible to maintain therapeutic compliance, with a loss to follow-up slightly higher than the previous year, suspensions and delays of tests could have significant negative consequences in the long term.
Comment in
-
The COVID-19 pandemic shows us in which way the care of patients with inflammatory bowel disease should move.Rev Esp Enferm Dig. 2021 Feb;113(2):153-154. doi: 10.17235/reed.2021.7765/2020. Rev Esp Enferm Dig. 2021. PMID: 33467860
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical